Treatment for Alzheimer’s disease in the future could involve something as simple as a nasal spray. Scientists have discovered that with a nasal spray, they can inhibit an enzyme and prevent the cognitive decline and brain damage that is typical of the disease.
A study led by Italian researchers has revealed an important mechanism underlying Alzheimer’s disease and has identified new therapeutic methods to combat this disease.
And one of these could be a nasal spray, after discovering that by inhibiting the brain enzyme S-acyltransferase (zDHHC), by spraying a drug, it is possible to combat degeneration cognitive and brain damage that is characteristic of the disease.
Researchers from the Faculty of Medicine and Surgery of the Catholic University and the IRCCS Polyclinic Foundation of the University of Agostino Gemelli have observed an excess of S-acyltransferase in the post-mortem brain of Alzheimer’s patients, which could be a promising therapeutic target. us medicines.
Higher concentrations of this enzyme were also associated with worse cognitive performance, the researchers found.
In experiments on genetically modified mice that reproduce Alzheimer’s disease, the researchers targeted the enzymes using an experimental nasal spray drug called “2-bromopalmitate,” they to write Science Alert. This approach successfully stopped neurodegeneration, reduced symptoms and even extended the animals’ lives.
2024-11-26 22:04:00
#Scientists #working #nasal #spray #stop #Alzheimers #tested #animals
Here are two PAA related to the transcript you provided:
## A New Hope: Could a Nasal Spray Be the Future of Alzheimer’s Treatment?
**(Introduction Music)**
**Host:** Welcome back to World Today News. Tonight, we delve into a groundbreaking discovery that holds immense promise for millions suffering from Alzheimer’s disease. Exciting new research suggests a simple nasal spray could be the key to slowing, or even stopping, the devastating effects of this debilitating condition. Joining us to unpack this revolutionary development are Dr. Emily Carter, a leading neuroscientist specializing in neurodegenerative diseases, and Mr. Peter Anderson, a passionate advocate for Alzheimer’s research and support, whose mother bravely battled the disease.
**(Transition Music)**
**Theme 1: The Science Behind the Breakthrough**
**Host:** Dr. Carter, your research focuses on the complexities of the brain, and this latest discovery seems incredibly novel. Can you walk us through the science behind this potential nasal spray treatment?
**Dr. Carter:** Absolutely. The study found an enzyme called S-acyltransferase, or zDHHC, is present in abnormally high levels in the brains of Alzheimer’s patients. This enzyme appears to play a crucial role in the development of the disease.
**Host:** So, essentially, this nasal spray aims to inhibit this enzyme’s activity?
**Dr. Carter:** Precisely. By targeting and reducing the levels of zDHHC, the researchers were able to see significant improvements in the cognitive abilities of mice genetically modified to have Alzheimer’s-like symptoms.
**Host:** What were some of the specific improvements observed in these mice?
**Dr. Carter:** They observed a reduction in neurodegeneration, meaning less damage to brain cells. There were also improvements in memory and cognitive function, and even an extension of their lifespan.
**(Transition Music)**
**Theme 2: Hope and Real-World Impact**
**Host:** Mr. Anderson, you’ve been closely involved in the fight against Alzheimer’s, having witnessed its devastating effects firsthand. What are your thoughts on this potential breakthrough?
**Mr. Anderson:** This news brings a glimmer of hope to millions of families struggling with this disease. Seeing tangible progress like this is incredibly encouraging. My mother endured the heartbreaking decline associated with Alzheimer’s, and knowing that a solution might be within reach gives me immense hope for future generations.
**Host:** What do you think this discovery means for the future of Alzheimer’s treatment?
**Mr. Anderson:** This could be a game-changer. A simple nasal spray, if proven successful in human trials, could be a more accessible and convenient treatment option compared to existing therapies, which can be invasive or have significant side effects.
**(Transition Music)**
**Theme 3: Challenges and the Road Ahead**
**Host:** Dr. Carter, while this is a promising development, what are some of the hurdles that need to be overcome before a nasal spray truly becomes a reality for patients?
**Dr. Carter:**
While the results in mice are encouraging, we need to exercise caution. Human trials are essential to determine the efficacy and safety of this approach in humans. Additionally, we need to ensure the spray effectively reaches the target areas in the brain and doesn’t cause unintended side effects.
**Host:** What timeline are we looking at for potential human trials and eventual availability?
**Dr. Carter:** It’s difficult to put a definitive timeline on it, but given the promising initial results, we’re hopeful that human trials could begin within the next few years.
**(Transition Music)**
**Host:** This is indeed a story of hope and scientific progress. We thank Dr. Emily Carter and Mr. Peter Anderson for sharing their invaluable insights.
**(Outro Music)**
